INVESTOR OVERVIEWCorporate ProfileRhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. More >>Recent NewsMore >>06/25/18Rhythm Pharmaceuticals, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares06/20/18Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering06/18/18Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering RYTM (Common Stock) $32.920.00 (0.00%)07/16/18 4:00 p.m. ETData provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and SourcesUpcoming EventsMore >>There are currently no events scheduled.